Glial Fibrillary Acidic Protein, Antibody

Cat.# 4G25

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

MAbs:
Price:
-- / mg
* All prices excluding VAT
Request an offer
Neuroscience
  • Cat.#

    4G25

  • MAbs:

    GFAP15cc, GFAP81cc, GFAP83cc, GFAP94cc, GFAP98cc, GF5
    Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with native human GFAP (MAbs GFAP81cc, GFAP83cc, GFAP94cc and GFAP98cc, GF5) or with synthetic peptide 1AGFKETRASERAEMME16 corresponding to 60-75 a.a.r. of GFAP conjugated with a carrier protein (MAb GFAP15cc).

  • Specificity:

    Human GFAP

  • MAb isotypes:

    IgG1 for MAbs GFAP15cc, GFAP81cc, GFAP83cc, GFAP94cc, GFAP98cc
    IgG2b
    for MAb GF5

  • Applications:

    Recommended pairs for sandwich immunoassay (capture – detection): GFAP83cc – GFAP81cc, GFAP94cc – GFAP98cc, GFAP15cc – GFAP81cc
    MAbs GFAP15cc, GFAP81cc, GFAP83cc, GFAP94cc and GFAP98cc are recommended for Western blotting.
    MAbs GFAP15cc, GFAP81cc, GFAP83cc and GF5 are recommended for immunohistochemistry.
    MAb GF5 is working in ELISA and indirect immunofluorescence staining.

  • Purification:

    Chromatography on protein A Sepharose (MAbs GFAP15cc, GFAP81cc, GFAP83cc, GFAP94cc, GFAP98cc)
    Chromatography on protein G Sepharose (MAb GF5)

  • Presentation:

    PBS, pH 7.4, 0.09 % sodium azide (NaN)

  • Storage:

    +4 °C (+2 … +8 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

    Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

×

Bulk Price Quotation

Glial Fibrillary Acidic Protein, Antibody (MAb: )

Information

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!